Please complete the CAPTCHA to continue
@primegenomics.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Robert Feldman is listed as Biotech Executive/Advisor/Entrepreneur at Fluxus Inc., based in Santa Cruz, California, United States. AeroLeads shows a work email signal at primegenomics.com and a matched LinkedIn profile for Robert Feldman.
Robert Feldman previously worked as Senior Vice President, Business Development and Strategic Initiatives at Fluxus Inc. and Senior Advisor at Fluxus Inc.. Robert Feldman holds Ph.D., Genetics from University Of Hawaii At Manoa.
This section adds company-level context without repeating Robert Feldman's masked contact details.
AeroLeads found 2 current-domain work email signals for Robert Feldman. Compare company email patterns before reaching out.
Biotech executive, board member and advisor with experience and demonstrated success founding startups, working in rapidly scaling growth companies leading to IPOs and helping position large international companies moving through M&As. Exceptional relationship builder, networker to investors, VCs, technical experts, strategic partners and team builders. Domain and leadership expertise in complex multi-stakeholder biotech, diagnostics, genomics, bioinformatics, product development, marketing, sales and support programs. Business acumen in strategy and corporate development. Excels in high stress dynamic environments and situations where pragmatic leadership and decision making is essential.CORE COMPETENCIES AND SKILLSBiotech executive: Startup formation, vision creation, fund raising, value creation, hiring, leading and managing diverse teams of scientists, marketing/sales forces from company inception through R&D to product/service specification launch, sales, growth and support. Strategic business development: Extensive network of investors, technical experts, strategic partners. Skilled in competitive analysis and positioning, identification of complementary technologies, deal structuring, negotiation and deal closing for corporate development.Domain expertise: Business development, strategy, competitive analysis, operations, investor relations, board management, program management and development of diagnostics, biotech, genomics, NGS, bioinformatics programs to applications, products and services for medical genetics and cancer, clinical collaborations, diagnostics, microbiome.PublicationsIn several roles I have built world class teams initiating and leading collaborations bridging academic KOLs to the company. Our work in microbial genomics of deep sea hydrothermal vent organisms, ecological metagenomics and human microbiomics resulted in seminal, high profile, high impact works co-authored and published in Nature, Science and PNAS. From a list of over 40 publications, (according to Google Scholar), these publications have over 12,000 citations; 18 have over 100, 4 have over 1,000 and 1 has been cited more than 5,300 times.
Listed skills include Genomics, Biotechnology, Bioinformatics, Dna Sequencing, and 24 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Sunnyvale, California, US
Fluxus is developing and commercializing biochip-based, opto-fluidic, single molecule detection platforms for ultra-high sensitivity diagnostics and biosensor applications. Fluxus was recently acquired by, and is now a wholly owned subsidiary of Fujirebio Inc, a global leader and historical pioneer in high performance IVD and clinical diagnostics. Our.
Santa Cruz, California, US
RealSeq’s industry leading small RNA and miRNA NGS library technology allows broad detection with “best in class” low bias. The company have commercialized a wide range of sequencing services including library preparation from extracted RNA or ready-to-sequence pooled libraries, bioinformatic and reagent kits. The company has raised their first funding.
Santa Clara, CA, US
Silicon Catalyst is the world’s only incubator + accelerator focused on semiconductor solutions, including Photonics, MEMS, sensors, IP, materials and Life Science. We accelerate startups from idea through prototype, and onto a path to volume production. I am advising on applicant companies in the life sciences.
Livermore, California, US
S2 Genomics enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. I am advising the CEO and CSO on business and corporate development.
Livermore, California, US
Buzzkill Labs is modernizing drug testing for a world of legal cannabis by developing innovative technology combining noninvasive sampling with sensitive detection and quantitation. I provided strategic advising to the founder, lead investor and board.
Prime Genomics (morphed into AeenaDx, merged with NowDx) was a noninvasive disease diagnostic company focused on transforming breast cancer screening. I took on the company at a critical time and navigated through key hiring, R&D, product specification, fund raising and operation commencement including remote clinical sample collection. Recruited by the.
Palo Alto, California, US
Within Centrillion, I founded and ran an Illumina based genomics and bioinformatics service business as General Manager with P&L responsibilities. Led all aspects of sales, marketing, product/service development, project management, customer support. Services included exome sequencing, RNAseq, whole genomes, GWAS on microarray systems, bioinformatics.
I founded SymBio as a $3.5M spinoff from Amersham Biosciences via bootstrapping contracts. SymBio was a genomics service partner for academic, medical and industrial researchers. Led grants as PI and administrator of NSF, NIH awards and sub awards, PI on deep-sea metagenomics projects, medical projects including lung cancer RNA sequencing, HIV sequencing.
Newark, DE, US
Metagenomic studies of microbial populations of deep sea hydrothermal vent associated microbes.
I founded the high-throughput genomic lab conducting high visibility R&D projects for alpha and beta testing of DNA seq and bioinformatics platforms. Provided marketing and sales support of MegaBACE instruments, TempliPhi reagents, and Cimarron SW platforms for high throughput genomics customers (JGI, Wash U, Whitehead, BGI, UWash, Baylor). Our platforms.
Diversa was a groundbreaking genomics and bioinformatics development company creating and mining environmental metagenomic expression libraries for enzymes for pharmaceutical, agriculture, chemical processing, oil production, etc. Participated in >$200M IPO, at that time, the largest ever for a genomics tools company. I co-developed company wide.
New Brunswick, NJ, US
Genetic studies of microbial symbionts of deep sea hydrothermal vent invertebrates
Quick answers generated from the profile data available on this page.
Robert Feldman works for Fluxus Inc..
Robert Feldman is listed as Biotech Executive/Advisor/Entrepreneur at Fluxus Inc..
AeroLeads has found 2 work email signals at @primegenomics.com for Robert Feldman at Fluxus Inc..
Robert Feldman is based in Santa Cruz, California, United States while working with Fluxus Inc..
Robert Feldman has worked for Fluxus Inc., Realseq Biosciences, Silicon Catalyst, S2 Genomics, and Buzzkill Labs.
You can use AeroLeads to view verified contact signals for Robert Feldman at Fluxus Inc., including work email, phone, and LinkedIn data when available.
Robert Feldman holds Ph.D., Genetics from University Of Hawaii At Manoa.
Robert Feldman is listed with skills including Genomics, Biotechnology, Bioinformatics, Dna Sequencing, Genetics, Commercialization, R&D, and Microbiology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts